UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004975
Receipt number R000005878
Scientific Title A safety study of perioperative olprinone administration for liver resection
Date of disclosure of the study information 2011/05/01
Last modified on 2021/03/18 09:56:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A safety study of perioperative olprinone administration for liver resection

Acronym

A safety study of olprinone for liver resection

Scientific Title

A safety study of perioperative olprinone administration for liver resection

Scientific Title:Acronym

A safety study of olprinone for liver resection

Region

Japan


Condition

Condition

Primary liver cancer
Metastatic liver cancer

Classification by specialty

Hepato-biliary-pancreatic surgery Operative medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To examine the safety of perioperative olprinone administration and its protective effects against postoperative dysfunction after liver resection

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase I,II


Assessment

Primary outcomes

Safety

Key secondary outcomes

Protective effects on the liver


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Perioperative olprinone administration

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Primary or metastatic liver cancer confirmed by clinical or histopathological examinations
2) Resectable liver cancer
3) Child Pugh classification A or B
4) Performance status 0-1
5) Adequate organ function
6) Ability of self-determination
7) Written informed consent

Key exclusion criteria

1) Biliary reconstruction
2) Gastrointestinal resection and lymphatic dissection
3) Preoperative percutaneous transhepatic portal embolization
4) Active double cancer
5) Serious complications such as heart or renal failure
6) A history of severe hypersensitivity

Target sample size

35


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Etsuro Hatano

Organization

Kyoto University Hospital

Division name

Department of Surgery

Zip code


Address

54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto

TEL

075-751-3242

Email



Public contact

Name of contact person

1st name
Middle name
Last name Kenya Yamanaka

Organization

Kyoto University Hospital

Division name

Department of Surgery

Zip code


Address


TEL

075-751-3242

Homepage URL


Email

kenya.y@hx5.ecs.kyoto-u.ac.jp


Sponsor or person

Institute

Department of Surgery, Graduate School of Medicine, Kyoto University

Institute

Department

Personal name



Funding Source

Organization

Department of Surgery, Graduate School of Medicine, Kyoto University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 01 Month 20 Day

Date of IRB

2011 Year 06 Month 01 Day

Anticipated trial start date

2011 Year 06 Month 01 Day

Last follow-up date

2021 Year 03 Month 18 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 01 Month 28 Day

Last modified on

2021 Year 03 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005878


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name